Literature DB >> 24787052

Long-range DNA interactions at the IL-1/IL-36/IL-37 gene cluster (2q13) are induced by activation of monocytes.

Nazar Sharaf1, Martin J Nicklin1, Francesco S di Giovine2.   

Abstract

The interleukin-1 gene cluster occupies a 360kb region of chromosome 2q13 and contains nine homologous genes. These include agonists and antagonists of the parallel IL-1 and IL-36 systems, and IL1F7, the gene encoding IL-37. As the genes of the cluster are structurally and functionally related and have similar mRNA kinetics, we have sought evidence for gene induction-specific looping of chromatin in the IL-1 cluster by chromatin conformation capture (3C). We show here that IL1A, IL1B and IL1F7 regulatory regions come in close proximity in LPS stimulated cells but not in resting human monocytes. This suggests that IL1A, IL1B and IL1F7 are likely transcribed by the same transcription factory. One cardinal function of transcriptional Locus Control Region (LCR) is bringing map-distant activated genes into close physical proximity within the transcription factory. Our data show distant intergenic DNA segments are also in close proximity to the regulatory regions of the three genes. This may indicate that they are co-regulated and raise the possibility of a LCR within the cluster.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chromosome conformation capture; Gene regulation; Inflammation; Interleukin 1; Locus Control Region

Mesh:

Substances:

Year:  2014        PMID: 24787052     DOI: 10.1016/j.cyto.2014.03.002

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  11 in total

Review 1.  Epigenetic reprogramming of immune cells in injury, repair, and resolution.

Authors:  Katarzyna Placek; Joachim L Schultze; Anna C Aschenbrenner
Journal:  J Clin Invest       Date:  2019-07-22       Impact factor: 14.808

Review 2.  Epigenetic Regulation of Inflammatory Signaling and Inflammation-Induced Cancer.

Authors:  Shawn Ying Xuan Tan; Jieqiong Zhang; Wee-Wei Tee
Journal:  Front Cell Dev Biol       Date:  2022-06-08

Review 3.  Suppression of innate inflammation and immunity by interleukin-37.

Authors:  Charles A Dinarello; Claudia Nold-Petry; Marcel Nold; Mayumi Fujita; Suzhao Li; Soohyun Kim; Philip Bufler
Journal:  Eur J Immunol       Date:  2016-05       Impact factor: 5.532

Review 4.  Overview of the IL-1 family in innate inflammation and acquired immunity.

Authors:  Charles A Dinarello
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

Review 5.  Potential role of IL-37 in atherosclerosis.

Authors:  Sara McCurdy; Chloe A Liu; Jonathan Yap; William A Boisvert
Journal:  Cytokine       Date:  2017-10-05       Impact factor: 3.861

6.  Genetic analysis of innate immunity in Behcet's disease identifies an association with IL-37 and IL-18RAP.

Authors:  Handan Tan; Bolin Deng; Hongsong Yu; Yi Yang; Lin Ding; Qi Zhang; Jieying Qin; Aize Kijlstra; Rui Chen; Peizeng Yang
Journal:  Sci Rep       Date:  2016-10-24       Impact factor: 4.379

Review 7.  Higher-Order Chromatin Regulation of Inflammatory Gene Expression.

Authors:  Jin-Wen Xu; Shuang Ling; Jun Liu
Journal:  Mediators Inflamm       Date:  2017-04-09       Impact factor: 4.711

8.  Cynomolgus macaque IL37 polymorphism and control of SIV infection.

Authors:  Takashi Shiina; Shingo Suzuki; Nicolas Congy-Jolivet; Alice Aarnink; Henri-Jean Garchon; Nathalie Dereuddre-Bosquet; Bruno Vaslin; Nicolas Tchitchek; Delphine Desjardins; Brigitte Autran; Olivier Lambotte; Ioannis Theodorou; Roger Le Grand; Antoine Blancher
Journal:  Sci Rep       Date:  2019-05-28       Impact factor: 4.379

Review 9.  Current Understanding of IL-37 in Human Health and Disease.

Authors:  Zhangci Su; Xiaoan Tao
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

Review 10.  Regulation of Transcription Factor NF-κB in Its Natural Habitat: The Nucleus.

Authors:  Susanne Bacher; Johanna Meier-Soelch; Michael Kracht; M Lienhard Schmitz
Journal:  Cells       Date:  2021-03-29       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.